Cargando…
Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004013/ https://www.ncbi.nlm.nih.gov/pubmed/35410220 http://dx.doi.org/10.1186/s12967-022-03324-8 |
| _version_ | 1784686200617959424 |
|---|---|
| author | Ma, Dongshen Zhang, Qin Duan, Qianqian Tan, Yuan Sun, Tingting Qi, Chuang Qin, Yong Liu, Hui |
| author_facet | Ma, Dongshen Zhang, Qin Duan, Qianqian Tan, Yuan Sun, Tingting Qi, Chuang Qin, Yong Liu, Hui |
| author_sort | Ma, Dongshen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9004013 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90040132022-04-13 Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma Ma, Dongshen Zhang, Qin Duan, Qianqian Tan, Yuan Sun, Tingting Qi, Chuang Qin, Yong Liu, Hui J Transl Med Letter to the Editor BioMed Central 2022-04-11 /pmc/articles/PMC9004013/ /pubmed/35410220 http://dx.doi.org/10.1186/s12967-022-03324-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Ma, Dongshen Zhang, Qin Duan, Qianqian Tan, Yuan Sun, Tingting Qi, Chuang Qin, Yong Liu, Hui Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma |
| title | Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma |
| title_full | Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma |
| title_fullStr | Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma |
| title_full_unstemmed | Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma |
| title_short | Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma |
| title_sort | identification of igf1r mutation as a novel predictor of efficacious immunotherapy in melanoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004013/ https://www.ncbi.nlm.nih.gov/pubmed/35410220 http://dx.doi.org/10.1186/s12967-022-03324-8 |
| work_keys_str_mv | AT madongshen identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT zhangqin identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT duanqianqian identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT tanyuan identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT suntingting identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT qichuang identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT qinyong identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma AT liuhui identificationofigf1rmutationasanovelpredictorofefficaciousimmunotherapyinmelanoma |